Table 1.

Median values for TEG indices using 3 different assays measured preoperatively and on post-operative day 1 with 25th to 75th quartile values provided in parenthesis. Patients with good graft function were compared to patients with poor graft function for each index with each corresponding p-value provided. ∗ denotes statistical significance (p < 0.05).

Time	tPA	R Good	R Poor	P	Angle Good	Angle Poor	P	MA Good	MA Poor	P	LY30 Good	LY30 Poor	P
Pre	0	8.2 (6.5–9.5)	7.6 (6.7–9.0)	0.60	68 (60–70)	67 (65–70)	0.40	67 (63–71)	68 (65–72)	0.27	0.1 (0–1.1)	0 (0–0.5)	0.35
Pre	75	7.5 (6.3–8.9)	7.5 (6.5–8.8)	0.90	69 (65–71)	67 (62–71)	0.35	67 (60–71)	67 (62–70)	0.75	2.8 (0.7–4.6)	1.2 (0.2–5.0)	0.20
Pre	150	7.5 (6.1–9.1)	7.1 (6.6–8.6)	0.61	67 (62–71)	68 (62–72)	0.64	60 (55–68)	63 (55–69)	0.36	16 (4.9–29)	12 (4.9–37)	0.70
POD1	0	7.8 (7.0–8.9)	7.6 (6.5–8.7)	0.43	69 (64–70)	68 (64–71)	0.85	67 (64–70)	67 (65–71)	0.86	0.3 (0–1.0)	0.2 (0–0.8)	0.80
POD1	75	7.2 (6.2–8.1)	6.5 (5.9–7.7)	0.26	69 (63–72)	69 (65–72)	0.65	67 (63–69)	66 (63–72)	0.99	2.1 (1–6.6)	1.8 (0.8–3.0)	0.20
POD1	150	6.9 (5.8–8.0)	7.0 (5.8–8.5)	0.68	71 (66–73)	70 (64–72)	0.53	65 (58–67)	63 (60–70)	0.68	∗17∗ (6.9–34)	10 (2.7–20)	0.007

Abbreviations: “Pre”, preoperative; “POD1”, post-operative day 1; “tPA”, tissue plasminogen activator (0 ng/ml, 75 ng/ml, 150 ng/ml); “R Good”, R-time (minutes) for patients with good graft function; “R Poor” R-time (minutes) for patients with poor graft function; “Angle Good”, angle (degrees) for patients with good graft function; “Angle Poor”, angle (degrees) for patients with poor graft function; “MA Good”, maximum amplitude (millimeters) for patients with good graft function; “MA Poor”, maximum amplitude (millimeters) for patients with poor graft function; “LY30 Good”, percent lysis 30 min after maximum amplitude for patients with good graft function; “LY30 Poor”, percent lysis 30 min after maximum amplitude for patients with poor graft function.